Benzinga | Feb 17, 2021 08:28AM EST

Roth Capital Downgrades Kodiak Sciences to Neutral, Raises Price Target to $155

Roth Capital analyst Zegbeh Jallah downgrades Kodiak Sciences (NASDAQ:KOD) from Buy to Neutral and raises the price target from $133 to $155.